Current ncd data of following diseases hypertension, diabetes, obesity and cancer .
global hypertension prevalence statistics 2024 2025
global diabetes prevalence statistics 2024 2025 IDF
global obesity prevalence statistics 2024 2025 WHO
global cancer incidence mortality statistics 2024 2025 IARC
| Metric | Figure |
|---|---|
| Adults with hypertension (2024) | 1.4 billion (ages 30-79) |
| Global prevalence (30-79 yrs) | 33% of that age group |
| Unaware of their condition | ~600 million (44%) |
| Diagnosed & on treatment | ~630 million (44%) |
| Controlled hypertension | ~320 million (23%) |
| Growth since 1990 | Doubled from 650 million to 1.4 billion |
| Metric | Figure |
|---|---|
| Adults living with diabetes (2024) | 589 million (ages 20-79) - 1 in 9 adults |
| Global prevalence | 11.1% of the adult population |
| Deaths attributed to diabetes (2024) | 3.4 million (1 every 9 seconds) |
| Health expenditure | USD 1 trillion+ (338% increase over 17 years) |
| Projected cases by 2050 | 853 million |
| Living in LMICs | Over 4 in 5 (81%) |
| Type 1 diabetes (2025) | 9.5 million globally |
| Undiagnosed diabetes | ~240 million (estimated) |
| Region | People with Diabetes |
|---|---|
| Western Pacific | 215 million |
| South-East Asia | 107 million |
| Middle East & North Africa | 85 million |
| Europe | 66 million |
| North America & Caribbean | 56 million |
| South & Central America | 35 million |
| Africa | 25 million |
| Metric | Figure |
|---|---|
| Adults living with obesity (BMI ≥30) | ~880 million adults |
| Children/adolescents (ages 5-19) with obesity | ~159 million |
| Total with overweight OR obesity | ~3 billion people |
| Projected adults with obesity by 2030 | 1.13 billion (115% increase from 2010) |
| Premature deaths caused by overweight/obesity annually | 1.6 million (from related NCDs) |
| Metric | Figure |
|---|---|
| New cancer cases (2024) | 20.6 million |
| Cancer deaths (2024) | 9.8 million |
| 5-year prevalent cases | 54.2 million |
| Lifetime risk of developing cancer | 1 in 5 people |
| Lifetime risk of dying from cancer | 1 in 9 men; 1 in 13 women |
| Projected new cases by 2050 | 34.4 million (67% increase) |
| Rank | Cancer | New Cases | % of Total |
|---|---|---|---|
| 1 | Lung | 2.64 million | 12.8% |
| 2 | Female breast | 2.43 million | 11.8% |
| 3 | Colorectal | 2.04 million | 9.9% |
| 4 | Prostate | 1.55 million | 7.5% |
| 5 | Stomach | 0.98 million | 4.8% |
| Rank | Cancer | Deaths | % of Total |
|---|---|---|---|
| 1 | Lung | 1.86 million | 19.1% |
| 2 | Colorectal | 0.92 million | 9.4% |
| 3 | Liver | 0.73 million | 7.5% |
| 4 | Female breast | 0.69 million | 7.1% |
| 5 | Stomach | 0.64 million | 6.6% |
| Disease | Affected Globally | Annual Deaths | Projected Trend |
|---|---|---|---|
| Hypertension | 1.4 billion | ~10 million+ (CVD-related) | Rising, esp. LMICs |
| Diabetes | 589 million | 3.4 million | 853 million by 2050 |
| Obesity | ~1 billion (adults) | 1.6 million (NCD-related) | 1.13 billion by 2030 |
| Cancer | 54 million (5-yr prevalence) | 9.8 million | 34.4 million cases by 2050 |
Interconnection note: These four conditions are deeply linked. Obesity is a primary driver of type 2 diabetes, hypertension, and at least 13 types of cancer. Together, NCDs account for 74% of all global deaths annually, according to WHO.